Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19

BACKGROUND: Allergen-specific immunotherapy (AIT) is accepted as the only disease-modifying therapy for IgE-mediated allergic airway diseases and hymenoptera venom allergy. AIT requires repeated contact between patient and physician or nurse in the hospital. Because it is a long-term treatment, comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Erkoç, Merve, Öztürk, Betül Özdel, Mungan, Dilşad, Öztuna, Derya, Bavbek, Sevim, Demirel, Yavuz Selim, Aydın, Ömür, Sin, Betül Ayşe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819422/
https://www.ncbi.nlm.nih.gov/pubmed/35174057
http://dx.doi.org/10.5415/apallergy.2022.12.e6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819422/
https://www.ncbi.nlm.nih.gov/pubmed/35174057
http://dx.doi.org/10.5415/apallergy.2022.12.e6

Ejemplares similares